Biodistribution of three photosensitizers in dogs with spontaneous tumors

Veterinary Therapeutics

Volumn 4, Issue 2, 2003, Pages

  Komaromy, Andras ^a   Gloi, Aime ^a   Beck, Elsa ^a   Costa, Lais ^a   Eades, Susan ^a   Steinberg, H ^a  

^a NIH under contract P01 CA 43892   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 79251521018     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dougherty TJ, Grundey GB, Fiel R, et al: Photoradiation therapy II: Cure of animal tumors with hematoporphyrin and light. J Nat Cancer Inst 55(1):115-121, 1975.
2. Dougherty TJ, Cooper MT, Mang TS: Cutaneous phototoxicity occurrences in patients receiving Photofrin. Lasers Med Surg 10:485-488, 1990.
3. Bonnet R, Bernbaum M: Porphyrins as photosensitizers. Proc Ciba-Geigy Found Symp 146:40-59, 1989.
4. Frazier DL, Barnhill MA, Vdinh T, et al: Comparative pharmacokinetics of the photosensitizers tin ethyl etiopurpurin in dogs and rats. J Vet Pharmacol Ther 15:275-281, 1992.
5. Frazier DL, Milligan JA, Morgan AR, Overholt BF: Canine treatment with SnET2 for photodynamic therapy. SPIE 1203:196-201, 1990.
6. Brasseur N, Ouellet R, La Madeleine C, van Lier JE: Water-soluble aluminum phthalocyanie-polymer conjugates for PDT: Photodynamic activities and pharmacokinetics in tumour-bearing mice. Br J Cancer 80(10):1533-1541, 1999.
7. Berns MW, Dahlman A, Johnson FM, et al: In vitro cellular effects of hematoporphyrin derivative. Cancer Res 42:2325-2329, 1982.
8. Brodey RS: The use of naturally occurring cancer in domestic animals for research into human: General considerations and review of canine skeletal osteosarcoma. Yale J Biol Med 52:345-361, 1979.
9. Cotchin E: Comparative oncology: The veterinary contribution. Proc Royal Soc Med 69:17-24, 1976.
10. Gillette EL: Spontaneous neoplasm as models for therapeutics agents, in Fidler IJ, White RJ (eds:) Design of Models for Testing Cancer Therapeutics Agents. New York, Van Nostrand Reinhold, 1982, pp 185-192.
11. Lewis JJ, Brennan MF: Soft tissue sarcomas. Curr Probl Surg 33(10):817-872, 1996.
12. Skinner KA, Eilber FR: Soft tissue sarcoma nodal metastases: Biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5(1):121-127, 1996.
13. Misdorp W, Hart AA: Prognostic factors in canine mammary cancer. J Nat Cancer Inst 56:779-786, 1976.
14. Lilge L, O'Carrol C, Wilson BC: Solubilization technique for photosensitizer quantification in ex-vivo tissue samples. J Photochem Photobiol B 65(4):701-706, 1997.
15. Kessel D, Chou T-H: Tumor localization components of the porphyrin preparation hematoporphyrin derivative. Cancer Res 43:1991-1999, 1983.
16. Wilson BC, Firnau G, Jeeves WP, et al: Chromatographic analysis and tissue distribution of radiocopper-labeled haematoporphyrin derivatives. Lasers Med Sci 3:71-80, 1988.
17. Henderson BW, Vaughan L, Bellinier DA, Van Leengoedet H: Photosensitization of murine tumor, vasculature and skin by 5. Aminolevinic acid-induced porphyrin. Photochem Photobiol 62(4):780-789, 1995.
18. Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55(1): 145- 157, 1992.
19. Gomer JD, Dougherty TJ: Determination [3H] and [14C] Hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39:146-151, 1979.
20. Brown S, Vernon DI, Holroy JA, et al: Pharmacokinetics of Photofrin in man, in Spinelli R, Dal Fante M, Marchessini R (eds): Photodynamic Therapy and Biomedical Lasers. Amsterdam, Elsevier, 1992, pp 475-479.
21. Bellinier DA, Ho-Y-K, Pandley RK, et al: Distribution and elimination of Photofrin II in mice. J Photochem Photobiol B 50:221-228, 1989.
22. Frazier DL, Barnhill MA, Vdinh T, et al: Comparative pharmacokinetics of the photosensitizers tin ethyl etiopurpurin in dogs and rats. J Vet Pharmacol Ther 15:275-281 1992.
23. Reddi E, Lo Castro G, Biolo R, Jori G: Pharmacokinetics with Zn(II)-phthalocyanine in tumor bearing mice. Br J Cancer 56:597-600, 1987.
24. Reddi E, Zhou C, Biolo R, et al: Liposome or LDL-administered Zinc(II)-phthalocyanine as a photodynamic agent for tumors. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 61: 407-411, 1990.
25. Giullio J: Tumor photosensitizers: Selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B 36:87-93, 1996.
26. Bugelski PJ, Porter CW, Dougherty TJ: Autoradiographic distribution of hematoporphyrin derivative in normal and tumor of the mouse. Cancer Res 41: 4606-4612, 1981.
27. Korbelick M, Krosl G: Cellular levels of photosensitizers in tumor: The role of proximity to the blood supply. Br J Cancer 70:604-610, 1994.